67184-0531 : Gefitinib 250 mg Oral Tablet, Coated

Labeler: Qilu Pharmaceutical Co., Ltd.
Product Type: Human Prescription Drug
Drug Name:  Gefitinib
Dosage Form: Oral Tablet, Coated
Application #: ANDA211591
Rev. Date: 

NDC Package Codes:

  • 67184-0531-1: 30 TABLET, COATED IN 1 BOTTLE (67184‑0531‑1)
  • 67184-0531-2: 500 TABLET, COATED IN 1 BOTTLE (67184‑0531‑2)
  • 67184-0531-3: 3 BLISTER PACK IN 1 CARTON (67184‑0531‑3) / 10 TABLET, COATED IN 1 BLISTER PACK

Active Ingredients:

  • Gefitinib

Dosage Strength:

  • 250 mg

Pharmaceutical Classes:

  • Kinase Inhibitor [EPC]
  • Protein Kinase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0480-4053 Gefitinib 250 mg Oral Tablet, Film Coated by Teva Pharmaceuticals, Inc.
  • 50742-366 Gefitinib 250 mg Oral Tablet, Coated by Ingenus Pharmaceuticals, LLC
  • 60505-4512 Gefitinib 250 mg Oral Tablet by Apotex Corp.
  • 69339-168 Gefitinib 250 mg Oral Tablet, Film Coated by Dash Pharmaceuticals LLC


Scan the QR code below to easily reference this data in the future:

NDC 67184-0531 QR Code

< Prev: 67184-0530Next: 67184-0532 >

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.